Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that it has successfully completed the acquisition of IVERIC bio, Inc. (NASDAQ: ISEE, CEO: Glenn P. Sblendorio, "Iveric Bio") with respect to the announcement on April 30, 2023, through its indirect wholly-owned subsidiary Berry Merger Sub, Inc. (the "Acquisition"). The Acquisition was completed on July 11, 2023, US Eastern Time, as follows, and Iveric Bio has become Astellas' wholly-owned subsidiary.
PARSIPPANY, N.J., July 05, 2023--Iveric Bio granted equity-based awards pursuant to the Company’s 2019 Inducement Stock Incentive Plan to 23 newly-hired, non-executive employees.
Annexon (ANNX) announces mixed top-line results from the phase II study of ANX007 in patients with geographic atrophy.
Astellas Pharma snapped up Iveric Bio for $5.9 billion in cash, the companies said Monday in an announcement that sent ISEE stock flying.
JPMorgan Chase is acquiring all the deposits and 'substantially all of the assets' of regional lender First Republic Bank, the FDIC says. Iveric Bio is being bought by Japan's Astellas Pharma for $5.9 billion.
Benzinga First Republic Folds As Banking Crisis Claims Third Victim: JPMorgan To Buy Deposits, Assets The First Republic Bank (NYSE: FRC) saga is winding to a close, with the Federal Deposit Insurance Corporation confirming the shuttering of the bank and the sale of its assets to JPMorgan Chase & Co. (NYSE: JPM). The California Department of Financial Protection and Innovation closed San Francisco-based First Republic on Monday. The FDIC was appointed receiver, a statement released by the federa
CARD JPMorgan Chase is acquiring all the deposits and 'substantially all of the assets' of regional lender First Republic Bank, the FDIC says. Iveric Bio is being bought by Japan's Astellas Pharma for $5.
Japanese healthcare company Astellas Pharma Inc (OTC: ALPMY) has agreed to buy Iveric Bio Inc (NASDAQ: ISEE) for $40.00 per share in cash for a total equity value of approximately $5.9 billion. Iveric Bio focuses on discovering and developing novel treatments in the field of ophthalmology. Astellas expects the deal to advance its primary focus on "Blindness & Regeneration." Related: IVERIC Bio's Geographic Atrophy Candidate Shows Significant Reduction In Disease Progression. The company announce
Japan's Astellas agrees to pay $40 a share for Iveric, citing the potential of the biopharmaceutical company's ophthalmology programs.
Astellas Pharma has agreed to buy US biotech group Iveric Bio for roughly $5.9bn, marking the Japanese drugmaker’s largest-ever acquisition and giving it access to the rapidly expanding market for age-related eye diseases. Astellas’s new chief executive Naoki Okamura said in an interview with the Financial Times that he was “not yet satisfied” and open to additional acquisitions to strengthen the group’s growth prospects. Astellas said on Monday that it would use cash and loans to buy the New ...